HOME Research Insight Bio-Rad Laboratories and Thermo Fisher Scientific, Inc. Dominate the Global Western Blotting Market

Bio-Rad Laboratories and Thermo Fisher Scientific, Inc. Dominate the Global Western Blotting Market

The global western blotting market is dominated by five major players, namely, Bio-Rad Laboratories (U.S.), Thermo Fisher Scientific, Inc. (U.S.), GE Healthcare (U.K.), Merck Millipore (U.S.), and Sigma-Aldrich Corporation (U.S.). These players jointly account for approximately 86% of the total western blotting market.

Thermo Fisher Scientific, Inc. accounted for the largest share of the western blotting market. The company’s western blotting products are widely used across the end-user market, thus positioning it as a market leader. The company strengthened its position in the market with the help of acquisitions and new product launches, which helped to increases the product portfolio of the company. For instance, in 2014, Thermo Fisher Scientific, Inc. acquired Life Technologies (U.S.) which helped the company to expand its footprint in life sciences solutions. Additionally, the company has a high focus on the high growth markets. For Instance, in 2013, the company expanded its customer base in the emerging Asia-Pacific region through the development of the China Innovation Center in Shanghai.

Bio-Rad Laboratories is another major player in the western blotting market. The company has a well-established brand and operates across Europe, U.S., and Asia. The company’s life sciences segment develops, manufactures, and markets a range of over 5,000 reagents, apparatus, and laboratory instruments to its customers. The company focuses on acquisitions and investments in companies with complementary products and technologies. For instance, in 2013, Bio-Rad Laboratories acquired AbD Serotec (U.K.) which led to an increase in its customer base.

Various key growth strategies such as new product launches, agreements, partnerships and collaborations, expansions, acquisitions, and others were adopted by key players in the western blotting market to expand their global footprints and to increase their market shares. For instance, in October 2013, GE Healthcare (U.K.) launched the Amersham Protran nitrocellulose membranes and Amersham Hybond PVDF membranes combining the product ranges of Whatman and Hybond Western blotting membranes. The launch of this product helped the company to offer researchers the ability to quickly and easily automate complete workflows. Thus, market players are investing both efforts and resources in growth strategies to gain a competitive edge in the western blotting market. 

Related Reports:

Western Blotting Market by Product (Instruments (Manual/Semi-automated/Automated), Consumables (Kits/Reagents/Membrane), by Application (Disease Diagnosis/Agriculture/Biomedical Research) - End-User Analysis & Global Forecast to 2018

Mr. Rohan
North - Dominion Plaza, 
17304 Preston Road, 
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support

US : 1-888-600-6441

Search reports